Clinical Trial Update: A Randomised,Multi-Center Study of Docetaxol Plus Capecitabine or Cisplatin in Anthracycline-Pretreated Patients With Advanced Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 randomized, multi-center trial assessing docetaxel plus capecitabine versus cisplatin in anthracycline-pretreated patients with advanced breast cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Capecitabine (capecitabine)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Academy Military Medical Science, China | Conditions: Advanced Breast Cancer | Phase 2 | Status: UNKNOWN